A boy is supported by his family and care team as a child but feels left with questions as an adult. In the United States, there are currently more adults living with cerebral palsy than children.
NEW YORK, NY, UNITED STATES, October 21, 2025 /EINPresswire.com/ -- The Cerebral Palsy Foundation (CPF) has been awarded funding through the Eugene Washington PCORI ...
Pain and symptom management are important parts of caring for adults living with cerebral palsy. However, these patients are often treated with medications that may not align with the underlying type ...
Because the majority of people living with cerebral palsy (CP) are adults, a focus on adult care in addition to pediatric and adolescent care is increasingly important to address their needs. A ...
LOS ANGELES--(BUSINESS WIRE)--SpineX Inc. today announced groundbreaking results in its first in-human study treating an adult with Cerebral Palsy (CP). The study, published in the esteemed medical ...
Cerebral palsy is the most common lifelong physical disability, affecting an estimated 18 million people worldwide. Our recent research at the University of Surrey shows that misconceptions about ...
The KINECT-DCP trial evaluated the efficacy and safety of valbenazine in patients with dyskinesia due to cerebral palsy who experience choreiform movements.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants who ...
Some medications are seen as a 'fix-all' solution, not addressing the root problem. Pain and symptom management are important parts of caring for adults living with cerebral palsy. However, these ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results